EC Number   |
Title |
Organism |
|---|
   3.4.22.27 | Cathepsin S alters the expression of pro-inflammatory cytokines and MMP-9, partially through protease-activated receptor-2, in human corneal epithelial cells |
Homo sapiens |
| 3.4.22.27 | Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications |
Mus musculus |
| 3.4.22.27 | Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications |
Homo sapiens |
| 3.4.22.27 | Cathepsin S is involved in Th17 differentiation through the upregulation of IL-6 by activating PAR-2 after systemic exposure to lipopolysaccharide from Porphyromonas gingivalis |
Mus musculus |
| 3.4.22.27 | Cathepsin S of Sciaenops ocellatus identification, transcriptional expression and enzymatic activity |
Sciaenops ocellatus |
| 3.4.22.27 | Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization |
Mus musculus |
| 3.4.22.27 | Identification and activity of a paralog of cathepsin S from yellow catfish (Pelteobagrus fulvidraco) involved in immune response |
Tachysurus fulvidraco |
| 3.4.22.27 | 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors |
Homo sapiens |
| 3.4.22.27 | 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important |
Homo sapiens |
| 3.4.22.27 | 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors |
Homo sapiens |
